WIPO中国：医疗保健科技创新在产权组织全球奖中占主导地位

今年，产权组织全球奖的卫生部门获奖者数量创下历史新高, 该奖项通过表彰和支持利用知识产权战略的创新者，凸显了小企业和初创企业在推动全球具有影响力的医疗保健解决方案方面日益增长的重要性。

With a record number of health sector winners this year, the WIPO Global Awards underscore the growing importance of small enterprises and startups in driving impactful healthcare solutions worldwide by recognizing and supporting innovators who leverage IP-backed strategies.

产权组织全球奖

The WIPO Global Awards

世界知识产权组织（产权组织）于2024 年 7 月 12 日举办了第三届 产权组织全球奖颁奖典礼，重点表彰利用知识产权取得商业成功并产生社会影响的领先中小企业和初创企业。今年，医疗保健技术占据了颁奖舞台的主要位置，9 名 获奖者中有6 名专注于卫生部门。这些获奖者是从今年创纪录的来自 107 个国家的 660 多份申请中选出的佼佼者。

The World Intellectual Property Organization (WIPO) on held the third edition of the WIPO Global Awards, on 12 July 2024 spotlighting pioneering Small- and Medium-sized Enterprises (SMEs) and startups that leverage intellectual property (IP) for business success and social impact. This year, health technologies dominated the stage, with  six of the nine winners focusing on the health sector. These winners were selected to be the best from a record 660+ applications this year from 107 countries.

为医疗保健创新提供知识产权支持

IP support for Healthcare Innovations

今年卫生部门的获奖者展示了突出的创新成果，体现了创造力和影响力。

This year’s winners from the health sector presented remarkable innovations, showcasing creativity and impact.

来自中国的智愈医疗解决了治疗前列腺肥大手术需求得不到满足的问题。该公司开发了一种手术机器人，利用精确的水刀进行手术，减少了人工手术的需要。智愈医疗采取了战略性的知识产权管理方法，在中国和通过PCT 体系（即《专利合作条约》）申请专利，获得版权和商标注册，并将其专有技术作为商业秘密加以保护。公司的目标是注重知识产权资产管理，建立知识产权监督机制，鼓励持续创新和研发，加强与科研机构和大学的合作。此外，该公司还计划加大许可和技术转让力度。

Healinno Tech from China addresses the unmet demand for surgeries to treat enlarged prostrate. It has developed a surgical robot that uses precise stream of water to perform the surgery, reducing the need for manual surgeries. Healinno Tech has adopted a strategic approach to IP management by filing for patents in China and through the PCT system (i.e., under the Patent Cooperation Treaty), obtaining copyright and trademark registrations, and safeguarding its proprietary technology as trade secrets. It aims to focus on IP asset management, establish an IP monitoring mechanism, encourage continuous innovation and R&D, and strengthen cooperation with research institutes and universities. Additionally, it plans to amplify its licensing and technology transfer efforts.

来自阿根廷的Laboratorios Química Luar专门从事创新药物产品的开发，例如可以雾化形式吸入肺部的基于布洛芬的配方。对于2019 冠状病毒病和囊性纤维化等复杂且未得到充分治疗的病症，该产品尤其具有吸引力。其产品受美国、欧洲和 PCT 专利保护。Química Luar 严格按照国际标准化组织的相关标准进行知识产权和保密信息管理。

Argentina’s Laboratorios Química Luar specializes in the development of innovative pharmaceutical products such as an ibuprofen-based formula that can be nebulized in the form of a mist inhaled into lungs. It becomes particularly interesting for complex and underserved conditions such as COVID-19 and Cystic Fibrosis. The products are protected by patents granted in the United States, Europe and the PCT system. Química Luar follows strict IP and confidential information management practices in line with relevant standards from the International Organization for Standardization.

来自泰国的Meticuly利用根据个体解剖结构量身定制的3D 打印、人工智能设计的钛骨植入物，在知识产权保护的支持下，提高了患者的治疗效果。Meticuly 的知识产权组合包括专利、商业秘密、商标和版权的战略组合，这对其扩张、市场渗透和创收起到了重要作用。该公司已在美国提交了临时专利申请，并通过 PCT 申请将保护范围扩大到全球。该公司定期进行“自由实施”（ FTO ）分析，监测市场上的侵权和假冒行为。该公司还与泰国的大学签订了许可协议，目的是在不太容易进入的市场实现知识产权货币化。

Thailand’s Meticuly enhances patient outcomes with 3D-printed, AI-designed titanium bone implants tailored to individual anatomies, underpinned by IP protection. Meticuly’s IP portfolio includes a strategic mix of patents, trade secrets, trademarks, and copyrights, which has been instrumental in its expansion, market penetration and revenue generation. It has filed provisional patent applications in the United States, and PCT applications to extend protection globally. It regularly conducts Freedom to Operate (FTO) analyses and monitors the market for infringement and counterfeiting. It has also entered into licensing agreements with universities in Thailand, aiming to monetize its IP in less accessible markets.

来自土耳其的PONS Technology为农村地区提供了便捷的超声波成像，减少了妊娠并发症。在尼日利亚的村庄，这项技术仅在一个月内就将妊娠并发症从45% 降至 25% 。该公司的知识产权战略有两大支柱：“保护”和“合作”：“保护”包括就其核心创新获得专利权，如获得专利权的图像增强技术和人工智能驱动的导航系统。“合作”涉及许可机会和战略合作伙伴关系，特别是在资源有限的情况下。该公司还注重知识产权货币化和获得知识产权基础融资。

PONS Technology from Turkey provides accessible ultrasound imaging for rural areas, reducing pregnancy complications. In Nigerian villages, this technology lowered pregnancy complications from 45% to 25% in just one month. Its IP strategy rests on two pillars: “protection” and “collaboration”. “Protection” involves securing patents for its core innovations such as its patented image enhancement technology and AI-driven navigation system. “Collaboration” involves licensing opportunities and strategic partnerships, particularly in resource limiting settings. It is also focusing on monetizing its IP and securing IP bases financing.

来自科威特的ScansX利用其专利和商标，通过便携式人工智能扫描仪带来了脑损伤诊断的革新。ScansX 的目标是通过许可其知识产权，与研究机构、医院、非政府组织（ NGO ）合作以加速其技术的开发，并在主要国际市场获得专利权以在全球范围内保护其技术，从而最大限度地提高其影响力和收入。

Kuwait’s ScansX revolutionizes brain injury diagnostics with a portable, AI-powered scanner, leveraging its patents and trademarks. ScansX is aiming to maximize its impact and revenue by licensing its IPs, collaborating with research institutions, hospitals, non-governmental organizations (NGOs) to accelerate development of its technologies, and securing patents in key international markets to protects its technology globally.

来自新加坡的Vivo Surgical公司利用创新的电池供电医疗设备提高了野战医院的外科护理水平，并在20 多个国家开展了商业活动。该公司是其两款关键产品（手术照明设备和内窥镜机器人）专利的全球独占许可方。此外，该公司还与两家知名医院共同开发了便携式内窥镜，并已申请了临时专利。公司重视品牌战略，取得了商标注册，并在与分销商签订的协议中加入了明确的知识产权条款，规定分销商处理其商标使用。这些协议还涉及分销商对机密信息的处理。

Vivo Surgical from Singapore enhances field hospital surgical care with innovative, battery-powered medical devices, establishing a commercial presence in over 20 countries. It is the worldwide exclusive licensee of the patents for its two key products: a surgical lighting device and an endoscope robot. Additionally, Vivo Surgical co-developed a portable endoscope with two reputable hospitals and has filed a provisional patent for it. The company emphasizes its branding strategy by obtaining trademark registrations and including clear IP clauses in agreements with distributors addressing trademark use by them. These agreements also address the treatment of confidential information by the distributors.

这些获奖者代表了不同地区的发展中国家，满足了广泛的医疗保健需求，包括辅助护理、诊断、外科护理和非传染性疾病的治疗。他们的创新成果展示了有效的知识产权战略如何推动便携式、易于部署的医疗保健技术的发展，从而提高医疗保健和医疗解决方案的可及性。

These winners, representing developing countries across various regions, address a wide range of healthcare needs, including assistive care, diagnostics, surgical care, and the treatment of non-communicable diseases. Their innovations demonstrate how effective IP strategies can drive the development of portable, easy-to-deploy healthcare technologies, thereby enhancing access to healthcare and medical solutions.

2024年产权组织全球奖获奖者之一智愈医疗的代表在7月9日至17日产权组织成员国大会期间举行的颁奖典礼上。A representative of Healinno Tech, one of the winners of the 2024 WIPO Global Awards, at a ceremony held during the July 9-17 Assemblies of WIPO Member States. （图｜Photo：WIPO/Berrod）

再接再厉

Building on Success

卫生部门的历届获奖者利用该奖项加强了知识产权战略，扩大了创新规模。例如，Centro de Retina Medicay Quirúrigca（CRMQ），一家开发纳米技术视网膜给药系统的墨西哥公司，于 2023 年获奖，计划利用其知识产权组合建立国际分销网络。来自新加坡的 Lucence Lifesciences是2022 年的获奖者，获奖后 获得4600 万美元 融资 ，最近已进入美国市场。另一位2022 年获奖者，来自中国的 苏州瑞派宁科技有限公司通过马德里体系扩大了其知识产权组合，该公司认为马德里体系为其国际发展奠定了基础。今年的获奖者还有望利用该奖项和产权组织的相关服务拓展业务，为医疗保健体系的进步做出贡献。

Past winners from the health sector have utilized the awards to strengthen their IP strategies and scale their innovations. For instance, Centro de Retina Medica y Quirúrigca (CRMQ), a Mexican company developing a nanotech retinal drug delivery system that won in 2023, plans to leverage its IP portfolio to build an international distribution network. Lucence Lifesciences, a 2022 winner from Singapore, raised $46 million post-award and has recently launched in the United States market. Raycan from China, another 2022 winner, expanded its IP portfolio through the Madrid System, which the company credits for laying the foundation for international growth. This year’s winners are also expected to utilize the Awards and associated WIPO services to expand their business and contribute to the advancement of healthcare systems.

在产权组织全球奖颁奖典礼后举行的圆桌讨论中，本年度评选委员会成员菲利普·德沃强调了推广应对全球医疗和环境挑战的技术的重要性。产权组织全球奖司长马塞洛·迪彼得罗·佩拉尔塔希望获奖者成为本国知识产权制度和相关行政部门的“大使”，鼓励各国政府提高知识产权制度的成熟度，而不仅仅是提供知识产权。

In a round table discussion that followed the WIPO Global Awards ceremony, Phillipe Dewost, Member of the Jury for the Awards this year, emphasized the importance of initiatives that promote technologies addressing global health and environmental challenges. Marcelo Di Pietro Peralta, Director, WIPO Global Awards, hopes the winners will serve as “ambassadors” for IP systems and relevant administrative offices in their country, encouraging governments to enhance their sophistication and go beyond merely providing IP rights.

产权组织全球奖强调了知识产权在商业活动和商业化工作中的重要性，为医疗创新者提供了一个识别创新中的关键障碍并在全球范围内推动改进的范例。

Emphasizing the importance of IP in business and commercialization efforts, the WIPO Global Awards serves as a model for medical innovators on how to identify key obstacles in innovations and drive improvements globally.

更多卫生保健科技创新为更健康的未来铺平道路

More Health Tech Innovations Pave the Way for a Healthier Future

今年，产权组织全球奖的卫生部门获奖者数量创下历史新高, 该奖项通过表彰和支持利用知识产权战略的创新者，凸显了小企业和初创企业在推动全球具有影响力的医疗保健解决方案方面日益增长的重要性。

With a record number of health sector winners this year, the WIPO Global Awards underscore the growing importance of SMEs and startups in driving impactful healthcare solutions worldwide by recognizing and supporting innovators who leverage IP-backed strategies.

以往获奖者的成功故事和今年获奖者做出的承诺，都表明产权组织致力于培育和加快医疗创新，最终为改善全球医疗成果做出贡献。

The success stories of past winners and the commitments made by this year’s cohort demonstrate WIPO’s commitment to nurturing and accelerating healthcare innovation, ultimately contributing to improved global health outcomes.